Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Ebola Analysis Finds Virus Hasn't Become Deadlier, Yet

April 16, 2015 8:33 am | by University of Manchester | News | Comments

The surprising results demonstrate that whilst a high number of genetic changes have been recorded in the virus, it hasn’t changed at a functional level to become more or less virulent. Read more...


Novartis Announces New Phase 3 Data from CLL Drug Study

April 16, 2015 8:33 am | News | Comments

CLL, the most commonly diagnosed adult leukemia in Western countries, accounts for approximately 1 in 4 cases of all leukemia. Read more...


President Obama: Ebola Fighting Goal is to Prevent New Cases

April 16, 2015 8:30 am | by Jim Kuhnhenn, Associated Press | News | Comments

He pointed out that last week there were fewer than 40 cases in the region, with no cases reported in Liberia. Read more...


Melanoma Treatment Market Value to More than Quadruple to $5.64 Billion by 2023

April 16, 2015 8:26 am | by Fenix Leung, DPhil, GlobalData’s Oncology and Hematology Analyst | Articles | Comments

The global treatment market for melanoma will expand more than fourfold in value from $1.34 billion in 2013 to reach an estimated $5.64 billion by 2023. Read more...


Tumor-Only Genetic Sequencing May Mislead Cancer Therapy

April 15, 2015 2:03 pm | by Stephanie Guzowski, Editor | News | Comments

When it comes to sequencing patients’ tumor genomes to personalize cancer therapy, one very important step may be missing, suggest Johns Hopkins researchers: a point of comparison to patients’ noncancerous genomes. Read more...


Ending Religious Waivers for Vaccines Back for Heated Debate

April 15, 2015 11:57 am | by Associated Press | News | Comments

California lawmakers are preparing for another round of heated talks Wednesday on whether the state should prevent parents from seeking vaccination exemptions for their children because of religious or personal beliefs. Read more...


Ventana, Astellas to Leverage Diagnostic Tests for Targeted Cancer Treatments

April 15, 2015 11:49 am | News | Comments

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into master collaboration agreement with Astellas Pharma Inc., an R&D-driven global pharmaceutical company headquartered in Japan, to develop novel automated tissue diagnostics in support of therapeutic compounds in development. Read more...


IMS: U.S. Prescription Drug Spending Jumped 13% in 2014

April 15, 2015 11:40 am | by Linda A. Johnson, AP Business Writer | News | Comments

U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act. Read more..


How Molecule Protects Brain Cells in Parkinson’s Disease Model

April 15, 2015 11:35 am | by Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found how a widely known but little-studied enzyme protects brain cells in models of Parkinson’s disease. Read more...


Adherence to Blood Thinner Best With Pharmacist Management, Researcher Says

April 15, 2015 11:28 am | by Tracie White, Stanford University | News | Comments

Researchers found that adherence to a new-generation anticoagulant, used to prevent stroke in heart disease patients, is best at sites with pharmacist-led management. Read more...


Heart Metabolics, FDA Agree on Special Protocol Assessment for Perhexiline Single Phase 3 Trial

April 15, 2015 9:23 am | News | Comments

The FDA has agreed to a single, randomized, pivotal Phase 3 trial of 350 patients evaluating perhexiline for the treatment of moderate-to-severe HCM. Read more...


FDA Accepts Teva's NDA for Bendamustine

April 15, 2015 9:16 am | News | Comments

This NDA requests FDA approval of the rapid infusion bendamustine HCl product for the treatment of patients with chronic lymphocytic leukemia. Read more...


New Liver Cancer Treatment Approved in Europe

April 15, 2015 8:24 am | by University Medical Center Utrecht | News | Comments

A new treatment for liver cancer developed by the University Medical Center Utrecht has received the European CE mark for quality and safety. Read more...


French Legislators OK Health Care Reform Targeting Anorexia

April 15, 2015 8:23 am | by The Associated Press | News | Comments

France's lower house of Parliament approved a draft law Tuesday tackling a range of public health problems, from smoking and drinking to obesity and anorexia. Read more...


Sierra Leone Schools Re-Open After Ebola Closed for 9 Months

April 15, 2015 8:22 am | by Clarence Roy-Macaulay, Associated Press | News | Comments

Children in Sierra Leone returned to schools on Tuesday after staying at home for nine months because of the Ebola outbreak. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.